Analyst Ratings for Uroplasty (UPI)
UPI Rating Summary
UPI Price Target Summary
- Highest: $5.00 (McNicoll Lewis & Vlak)
- Lowest: $3.00 (MLV & Co.)
- Average: $4.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.50 (+106.4%)
Avg. $ Target:
$4.50 (+106.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2013 | MLV & Co. | Downgrade | Hold (Buy) |
3.00 (N/A) |
2.74 | 2.18 | -20.44% | Details |
| 1/22/2013 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
3.10 | 2.18 | -29.68% | Details |
| 9/20/2012 | Stephens | New Coverage | Overweight (N/A) |
5.00 (N/A) |
3.95 | 2.18 | -44.81% | Details |
| 5/22/2012 | Roth Capital | Upgrade | Buy (N/A) |
N/A (N/A) |
3.25 | 2.18 | -32.92% | Details |
| 3/1/2012 | McNicoll Lewis & Vlak | New Coverage | Buy (N/A) |
5.00 (N/A) |
2.76 | 2.18 | -21.01% | Details |
